Experimental drug daraxonrasib shows major benefit in pancreatic cancer trial

We're seeing major advances vs pancreatic cancer. Today @nejm.org data for daraxonrasib nejm.org/doi/full/10.... Context for this first-in-class molecular glue nejm.org/doi/full/10....

A new technique has been developed using an electronic jolt and nanoparticles to detect early signs of #PancreaticCancer. And in early testing, it spotted one of the hardest cancers to catch early with remarkable accuracy. #OHSUResearch:

This makes sense - and obviously now folks are familiar with mRNA vaccines and so have more basis to start from in reading about the phase 1 study, so potentially easier to go viral. I think there'll be another wave of publicity for daraxonrasib when data is shared at ASCO - so may also see it then

Just published in @nejm.org: RAS(ON) Inhibitor daraxonrasib shows promising results in advanced pancreatic cancer phase 1/2 study. @danafarber.bsky.social's Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research, is a lead investigator on the trial. bit.ly/4uvpS8w

An experimental drug doubled the survival time of pancreatic cancer patients. Doctors think it could revolutionize how the disease is treated. www.nbcnews.com/health/healt...

In a phase 1–2 study of daraxonrasib, treatment-related adverse events of grade 3 or higher occurred in 30% of patients with previously treated RAS-mutated pancreatic cancer, and up to 35% of patients had an objective response. Full study results: https://nej.md/4f7xfhX

How FDA Expanded Access for Daraxonrasib and Phase 3 Survival Data At Revolution Medicines (RVMD) Has Changed Its Investment Story https://www.newsbeep.com/ca/652341/ Revolution Medicines recently secured FDA clearance for an expanded access program for its investigational pancreatic cancer …

A landmark moment for one of cancer’s hardest fights: an oral drug called daraxonrasib nearly doubled survival in metastatic pancreatic cancer vs standard chemo; 13.2 months vs 6.7 months. #TCSC #CancerResearch #PancreaticCancer #Oncology www.onclive.com/view/daraxon...

👏🏻 'A watershed moment': A pancreatic cancer drug is set to transform treatment www.nbcnews.com/health/healt...

Does anyone find it interesting that NBC posted about this, not mentioning Israel 🤔 Israeli Company Develops New Treatment for Pancreatic Cancer - Atlanta Jewish Times share.google/Sjuu4QAkWSPW...